Earnings call transcript: PUMA beats revenue in Q3 2026 as shares rise 5.6%

PUMA’s Q3 2026 revenue of $1.78 billion beat estimates by $20 million, but adjusted EPS of -$0.37 missed the -$0.3284 forecast; currency-adjusted sales fell 6.3% year over year. Gross margin expanded 420 basis points to 49.5%, free cash flow was EUR 92 million, and net debt fell EUR 127 million year over year to EUR 1.1 billion. PUMA maintained its low-to-mid-single-digit currency-adjusted sales decline outlook for 2026, narrowed its EBIT guidance to -EUR 80 million to -EUR 130 million, and lowered CAPEX guidance to below EUR 150 million. Shares rose 5.59% to $26.62 after the report, while management described the recovery as gradual amid cautious consumers and retailers.

Analysis

The key issue is earnings quality, not the small revenue beat: margin expansion includes a tariff refund, while the remaining uplift still needs to prove durable through full-price sell-through and mix. Meanwhile, higher operating expense against a shrinking sales base leaves little operating leverage; management’s expectation of worse Q4 leverage makes the post-report rally vulnerable if investors extrapolate the gross-margin move into a rapid profit recovery.

Near term, inventory reduction and lower capex support liquidity, but cash conversion partly reflects lower purchasing and investment rather than demonstrated demand recovery. That distinction matters with net debt still elevated and bridge-loan refinancing underway. Track completion and terms of the remaining refinancing; a deterioration in credit access would raise the value of cash preservation and constrain brand investment.

Over 1–3 months, watch Q4 sell-through, wholesale orders, and the March 2027 outlook. Running/training momentum is encouraging but concentrated: it does not yet establish broader pricing power or recovery across core and football. ANTA’s stake may offer longer-term China distribution and execution benefits, but its near-term second-order effect is partner hesitation and weaker wholesale visibility; DTC growth may not fully offset that channel drag.

Contrarian read: the quarter is better evidence of a reset progressing than of a growth inflection. The market may be underpricing the time needed to convert selective distribution and category wins into scale, while over-crediting a partly non-recurring margin tailwind. No valuation data or peer estimates are supplied, so avoid asserting relative cheapness or a price target.

Key Decisions for Investors

• Do not chase the earnings-day rally. Treat PUM as a catalyst watch rather than a high-conviction directional trade until Q4 confirms underlying demand and margin durability.
• For a 1–3 month tactical stance, consider a small, defined-risk bearish position only if the shares give back the post-report gain alongside weaker sell-through or a guidance cut; invalidate it if Q4 sales improve and EBIT delivery is within the guided range. No price target is supported by the available data.
• Monitor gross margin excluding the tariff-refund contribution, operating-expense growth versus sales, inventory days, and free cash flow composition. Repeated cash generation without sales stabilization would be less persuasive than reported FCF alone.
• Track China wholesale orders and partner store activity separately from DTC, plus completion and terms of the remaining bridge refinancing. A wholesale stabilization and successful refinancing would weaken the cautious thesis; renewed partner pullback or adverse financing terms would strengthen it.